共 50 条
- [3] Adherence to biological therapies in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. (Study ADhER-1) [J]. MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (02): : 81 - 90
- [4] Differences in bone metabolism in ankylosing spondylitis. Psoriatic arthritis and reactive arthritis [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S233 - S233
- [5] Co-occurrences of selected cardiovascular diseases and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S34 - S35
- [6] Patient Satisfaction and Experience with Golimumab, Adalimumab, and Etanercept for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S817 - S817
- [8] BIOLOGIC USE IN NHS PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS [J]. RHEUMATOLOGY, 2016, 55 : 124 - 124
- [10] GolimumabIn the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis [J]. BioDrugs, 2009, 23 : 125 - 135